Drug Type Autologous CAR-T |
Synonyms Retroviral vector-transduced autologous T cells to express anti-ALPP CARs(Xinqiao Hospital) |
Target |
Mechanism ALPP inhibitors(alkaline phosphatase, placental inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseSuspendedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrial Carcinoma | Phase 2 | - | 13 Nov 2020 | |
Ovarian Cancer | Phase 2 | - | 13 Nov 2020 | |
Advanced Malignant Solid Neoplasm | Phase 2 | CN | 01 Jan 2018 |